Erratum to: Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology: J Natl Compr Canc Netw 2019;17(11):1374–1391.

In the November 2019 issue, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gestational Trophoblastic Neoplasia, Version 2.2019 (J Natl Compr Canc Netw 2019, doi: 10.6004/jnccn.2019.0053) contained an error.

In 2 places, “hypoglycosylated” should have read “hyperglycosylated.” On page 1378, the second sentence under the heading “Follow-up” should have read: “Therefore, monitoring should be performed with a quantitative assay capable of detecting all forms of hCG, including beta-hCG, core hCG, nicked-free beta, beta core, and hyperglycosylated forms.4,18,19” On page 1380, the last sentence of the second paragraph in the left column should have read: “Elevated hCG with normal hyperglycosylated hCG may indicate quiescent GTN not requiring immediate or further treatment.33

The online version has been corrected. The authors apologize for the error.

If the inline PDF is not rendering correctly, you can download the PDF file here.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 162 162 0
PDF Downloads 41 41 0
EPUB Downloads 0 0 0